Soleno Therapeutics, Inc. (SLNO)

May 18, 2026 - SLNO was delisted (reason: acquired by NBIX)

53.01

0.00 (0.00%)

Inactive · Last trade price on May 15, 2026

Soleno Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,763	2,487	1,938	1,228	16	33
Market Cap Growth	-19.91%	28.31%	57.88%	7498.61%	-50.63%	-78.71%
Enterprise Value	2,288	1,983	1,656	1,176	-3	5
Last Close Price	-	46.30	44.95	40.25	1.98	6.15

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	30.00	121.45	-	-	-	-
Forward PE	11.16	13.68	-	-	-	-
PS Ratio	9.69	13.06	-	-	-	-
PB Ratio	5.53	5.53	7.91	7.79	1.56	1.84
P/TBV Ratio	5.62	5.59	8.13	8.25	-	6.35
P/FCF Ratio	26.21	53.22	-	-	-	-
P/OCF Ratio	26.18	53.14	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	8.03	10.42	-	-	-	-
EV/EBITDA Ratio	25.00	116.90	-	-	-	-
EV/EBIT Ratio	25.57	132.67	-	-	-	-
EV/FCF Ratio	21.71	42.45	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.11	0.12	0.22	0.00	0.02	0.03
Debt / EBITDA Ratio	0.59	2.93	-	-	-	-
Debt / FCF Ratio	0.52	1.13	-	-	-	-
Net Debt / Equity Ratio	-0.96	-1.01	-1.08	-1.07	-1.40	-1.17
Net Debt / EBITDA Ratio	-5.19	-26.73	1.46	4.61	0.62	0.69
Net Debt / FCF Ratio	-4.50	-9.71	3.84	6.79	0.70	0.75
Asset Turnover	0.62	0.43	-	-	-	-
Quick Ratio	5.22	5.44	15.55	14.75	2.00	2.66
Current Ratio	5.62	5.80	15.68	14.89	2.14	2.80
Return on Equity (ROE)	26.38%	6.01%	-87.35%	-46.45%	-171.05%	-97.60%
Return on Assets (ROA)	12.07%	2.09%	-45.06%	-23.33%	-50.58%	-40.11%
Return on Capital Employed (ROCE)	16.30%	3.00%	-59.10%	-22.90%	-130.90%	-117.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	3.46%	0.84%	-9.07%	-3.18%	-148.97%	-94.47%
FCF Yield	3.82%	1.88%	-3.58%	-2.03%	-128.71%	-84.94%
Buyback Yield / Dilution	-26.81%	-30.39%	-143.61%	-96.40%	-57.90%	-27.39%

SEC Filings: 10-K · 10-Q